Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Bayer Completes Acquisition of Perfuse Therapeutics

Thursday, June 18, 2026

Bayer today announced the completion of the acquisition of Perfuse Therapeutics Inc As a result Perfuse Therapeutics will now be fully integrated into Bayer As announced previously Bayer

LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody

Thursday, June 18, 2026

LabGenius Therapeutics LabGenius a drug discovery company combining machine learning ML and highthroughput experimentation to optimise therapeutic antibodies today announced a multiyear research collaboration

Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

Thursday, June 18, 2026

Oncotelic Therapeutics Inc Oncotelic or the Company OTCQB OTLC today announced the completion of key Phase objectives in its joint manufacturing automation initiative with TechForce Robotics Inc

FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma

Thursday, June 18, 2026

Roche SIX RO ROP OTCQX RHHBY announced today that the US Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA for Lunsumio VELO

Cold Chain Technologies Launches CCT Rx Secure to Streamline Specialty Pharmacy Shipments

Thursday, June 18, 2026

Cold Chain Technologies has launched CCT Rx Secure a new digital application designed to support specialty pharmacies in making more informed repeatable packout decisions for temperaturesensitive shipments

Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas

Wednesday, June 17, 2026

Zai Lab Limited NASDAQ ZLAB HKEX today announced the European Medicines Agency EMA has granted Orphan Drug Designation ODD to zocilurtatug pelitecan zoci formerly ZL the Companys

USP and BPOM Open Registration for Joint Symposium on Pharmaceutical Quality and Regulatory Excellence in Jakarta

Wednesday, June 17, 2026

The United States Pharmacopeia USP and Badan Pengawas Obat dan Makanan BPOM the Indonesian Food and Drug Authority invite regulators industry players manufacturers and academic stakeholders to register

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry

Tuesday, June 16, 2026

Pelago Bioscience a specialist drug discovery focused contract research organization CRO known for its industryleading cellbased target engagement assays is pleased to announce the acquisition of RG Discovery

Lilly's Jaypirca significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL

Tuesday, June 16, 2026

Eli Lilly and Company NYSE LLY today announced results from the Phase BRUIN CLL clinical trial of Jaypirca pirtobrutinib a noncovalent Bruton tyrosine kinase BTK inhibitor plus venetoclax and rituximab versus

MattenPlant Expands into Pharmaceutical Water Solutions with Southeast Asia's First Locally Manufactured Cold WFI System at SIWW 2026

Tuesday, June 16, 2026

MattenPlant Pte Ltd Matten a Singaporebased specialist in industrial and municipal water and wastewater treatment announces the launch of its Pharmaceutical Water for Injection Cold WFI initiative bringing